Literature DB >> 21772295

Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?

R Byrne1, S E Yost, B Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21772295     DOI： 10.1038/clpt.2011.95

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

Review 1.  Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

Review 2.  The influence of UGT polymorphisms as biomarkers in solid organ transplantation.

Authors:  Robert Dupuis; Andrea Yuen; Federico Innocenti
Journal:  Clin Chim Acta       Date:  2012-02-01       Impact factor: 3.786

3.  Antiproliferatives and Transplantation.

Authors:  Robert Donovan; Howard Eisen; Omaima Ali
Journal:  Handb Exp Pharmacol       Date:  2022

Review 4.  Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention.

Authors:  David K Metz; Nick Holford; Joshua Y Kausman; Amanda Walker; Noel Cranswick; Christine E Staatz; Katherine A Barraclough; Francesco Ierino
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.